| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.39 | 0.04 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.04 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.37 | 0.05 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |